News

Indian pharmaceutical companies are gearing up to launch cost-effective versions of the weight-loss and diabetes drug, semaglutide, post patent expiry in 2026.
Teresa Seaton has won multiple glittering awards for her dazzling effort in helping people in Burton Latimer and Kettering to ...
Although GLP-1 drugs make headlines for vision risks, other weight-loss medications carry their own eye-related side effects.
Doctors highlight new weight-loss medications, early-onset diabetes, and pregnancy-related risks during Diabetes Awareness ...
It's estimated that around 1.5 million Brits are now taking weight-loss drugs, such as Wegovy, Ozempic, Mounjaro, Saxenda and Orlistat.
At the same time, and likely because of this, data shows that demand for bariatric surgery has plunged, dropping nearly 26 ...
People are reported a certain side effectA urologist has revealed the truth behind ‘Ozempic penis’ after men reported a ...
The side effects of taking Mounjaro can be very varied, and the drug tends to affect people differently. The most common side effects include feeling sick, diarrhoea, constipation, vomiting, heartburn ...
A study by GNC suggests that GLP-1s users are risking malnourishment and muscle loss. GNC announced the results of a study ...